Arbutus Biopharma Corporation (ABUS) Total Assets by Year
Arbutus Biopharma Corporation closed fiscal year 2025 with $94.6M in total assets, $18.0M in total liabilities and $76.6M in shareholder equity. This represents a decrease of 28.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Arbutus Biopharma Corporation has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
ABUS Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $94.6M-28.2% | $131.7M-8.8% | $144.4M-26.1% | $195.4M-4.4% | $204.5M+49.2% | $137.1M+29.9% | $105.5M-53.7% | $227.9M-3.9% | $237.2M-14.0% | $275.9M-61.3% | $712.3M+502.7% | $118.2M+64.8% | $71.7M | N/A | N/A |
| Total Liabilities | $18.0M-47.5% | $34.3M-10.5% | $38.4M-34.5% | $58.6M+67.1% | $35.0M-0.2% | $35.1M+7.1% | $32.8M+18.5% | $27.7M-49.4% | $54.7M-25.0% | $72.9M-55.7% | $164.6M+446.1% | $30.1M+140.7% | $12.5M | N/A | N/A |
| Total Equity | $76.6M-21.4% | $97.4M-8.2% | $106.0M-22.5% | $136.9M-19.2% | $169.4M+66.2% | $102.0M+40.2% | $72.7M-63.7% | $200.2M+9.7% | $182.5M-10.1% | $203.0M-62.9% | $547.7M+522.1% | $88.0M+48.7% | $59.2M+44.7% | $40.9M+682.7% | $5.2M |
ABUS Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $274.0M+165.4% | $277.2M+136.9% | $94.6M-28.2% | $97.7M-30.4% | $103.3M-35.5% | $117.0M-22.1% | $131.7M-8.8% | $140.4M-11.5% | $160.0M-9.5% | $150.3M-21.4% | $144.4M-26.1% | $158.6M-22.2% |
| Total Liabilities | $15.3M-24.6% | $17.0M-55.1% | $18.0M-47.5% | $20.3M-39.5% | $20.3M-46.0% | $37.9M+6.2% | $34.3M-10.5% | $33.6M-14.6% | $37.6M-10.8% | $35.7M-24.6% | $38.4M-34.5% | $39.3M-32.6% |
| Total Equity | $258.7M+211.8% | $260.2M+228.7% | $76.6M-21.4% | $77.4M-27.6% | $83.0M-32.2% | $79.2M-30.9% | $97.4M-8.2% | $106.9M-10.4% | $122.5M-9.1% | $114.6M-20.3% | $106.0M-22.5% | $119.3M-18.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Arbutus Biopharma Corporation financials
Frequently Asked Questions
What was Arbutus Biopharma Corporation's total assets in fiscal year 2025?
Arbutus Biopharma Corporation closed fiscal year 2025 with $94.6M in total assets, $18.0M in total liabilities and $76.6M in shareholder equity.
How fast is Arbutus Biopharma Corporation's total assets growing?
Arbutus Biopharma Corporation (ABUS) total assets fell by 28.2% year over year, from $131.7M to $94.6M in fiscal year 2025.
What was Arbutus Biopharma Corporation's total assets in the most recent quarter?
Arbutus Biopharma Corporation (ABUS) reported $274.0M in total assets in Q2 2026. This represents an increase of 165.4% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Arbutus Biopharma Corporation (ABUS) reported on that line in every period on record.